Promotional Review Committee (PRC)

Updated 2026-07-13 · markdown version

A Promotional Review Committee (PRC) is the named, cross-functional body that performs MLR review inside a pharmaceutical company. Its core seats are medical (scientific accuracy and substantiation), legal (liability), and regulatory (label and FDA/OPDP compliance); commercial and compliance functions frequently attend. The PRC's approval is the gate between a draft and a usable promotional asset.

Terminology varies by company: PRC, MRC (material review committee), MLR committee, copy review board. The mechanics are similar — materials are submitted to a queue with their reference packs, reviewed in committee (or asynchronously in a workflow system), findings are returned to the writer, and revised material re-enters the queue. Each pass is a "round."

The PRC is also where the economics of review live: reviewer hours are scarce and senior, meeting cadence bounds throughput, and every avoidable finding (an unsupported claim, a missing annotation) consumes a slot that a clean submission wouldn't. Practices that reduce findings-per-submission — claims matrices, rigorous annotated references, pre-review checks — are effectively PRC capacity multipliers.